What is the significance of the CEO's new performance-based stock award?

The CEO's new award is 100% tied to market capitalization and operational goals over 10 years, replacing a typical salary and bonus. For 2018, it's expected to generate approximately $3.0 million in stock-based compensation expense, recognized ratably from May 24th through year-end. This will impact GAAP net income but is excluded from Non-GAAP measures.

Why is Axon providing detailed GAAP to Non-GAAP reconciliations?

Axon is providing these reconciliations for the past five quarters to help investors and analysts compare historical performance. The company began presenting Non-GAAP net income in February 2018 and believes these measures, which exclude non-cash stock-based compensation and certain discrete items, offer a clearer view of ongoing operational performance.

Will the VIEVU acquisition costs affect Axon's annual guidance?

No, Axon states that the expected $1.0 million to $1.3 million in acquisition and integration costs for VIEVU in Q2 2018 are non-recurring and do not change the company's previously issued annual guidance from May 8, 2018. The guidance already excluded such transaction and integration costs, as well as stock-based compensation.

What is the difference between EBITDA and Adjusted EBITDA as presented by Axon?

EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is a measure of operating profitability. Adjusted EBITDA further excludes non-cash stock-based compensation expense and certain other specific items like gains/losses on asset disposals, providing a metric that management uses to assess operational performance and compare across periods, removing the impact of these non-operational or non-cash items.

AXON 8-K SEC Disclosure

Summary

This 8-K filing from Axon Enterprise, Inc. (AXON) provides updated financial information subsequent to their Q1 2018 filing, with a focus on share count, CEO compensation, and historical Non-GAAP financial data. Notably, Axon had 58,244,665 shares outstanding as of May 21, 2018, post-equity offering. A new performance-based equity award for the CEO was approved, expected to result in approximately $3.0 million in stock-based compensation expense for 2018, recognized ratably from May 24, 2018. The filing also presents detailed reconciliations of GAAP to Non-GAAP Net Income and EPS for the past five quarters, highlighting the impact of stock-based compensation and other discrete items. This data is provided to aid investors in comparing historical performance. The company also disclosed expected non-recurring acquisition and integration costs of $1.0 million to $1.3 million for the VIEVU acquisition in Q2 2018, while reaffirming its previously issued annual guidance.

Key Highlights

1As of May 21, 2018, Axon had 58,244,665 shares issued and outstanding, reflecting its recent follow-on equity offering.
2A new 10-year performance-based stock award for the CEO was approved, expected to incur ~$3.0 million in stock-based compensation expense during 2018.
3The company is providing a five-quarter reconciliation from GAAP to Non-GAAP Net Income and EPS, emphasizing stock-based compensation and other one-time items.
4Non-GAAP Net Income consistently exceeded GAAP Net Income across the presented periods due to significant stock-based compensation expenses.
5Adjusted EBITDA showed strong growth, increasing from $4,128k in Q2 2017 to $21,329k in Q1 2018, with Adjusted EBITDA margin also improving.
6Axon anticipates incurring $1.0 million to $1.3 million in acquisition and integration costs related to the VIEVU acquisition in Q2 2018.
7The company reaffirms its annual guidance previously issued on May 8, 2018, stating this supplemental information does not alter it.

AXON ENTERPRISE, INC. 8-K Report, Corporate Update (Jun 21, 2018)

Summary

Key Highlights

Frequently Asked Questions